Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $99.3000 (-3.12%) ($93.0000 - $106.8000) on Thu. Mar. 19, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.98% (three month average) | RSI | 77 | Latest Price | $99.3000(-3.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 6.2% a day on average for past five trading days. | Weekly Trend | CAPR advances 17.2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(7%) VT(7%) XLF(7%) EEM(6%) EWI(6%) | Factors Impacting CAPR price | CAPR will decline at least -4.49% in a week (0% probabilities). VIXM(-5%) TLT(-4%) GLD(-3%) SLV(-2%) SHY(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.49% (StdDev 8.98%) | Hourly BBV | 0 () | Intraday Trend | -6.8% | | | |
|
5 Day Moving Average | $86.54(14.74%) | 10 Day Moving Average | $80.98(22.62%) | 20 Day Moving Average | $71.53(38.82%) | To recent high | -3.1% | To recent low | 192.1% | Market Cap | $1.956b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |